BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Retina
,
Avian flu virus
,
Bleomycin
,
rs7903146
,
FOXP1
,
cell-cell adhesion
,
Ischemia
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
DR3
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Cerebellum peduncles
Cerebellum
T Lymphocyte (regulatory) of peripheral blood
T Lymphocyte (CD4+) of peripheral blood
Natural killer cell of peripheral blood
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
The cytokine receptor DR3 identifies and promotes the activation of thymic NKT17 cells.
HLA-DR3 restricted environmental epitopes from the bacterium Clostridium tetani have T cell cross-re…
Direct signaling of TL1A-DR3 on fibroblasts induces intestinal fibrosis in vivo.
Targeting TL1A/DR3 Signaling Offers a Therapeutic Advantage to Neutralizing IL13/IL4Rα in Muco-Secre…
Death-Domain-Receptor 3 Deletion Normalizes Inflammatory Gene Expression and Prevents Ileitis in Exp…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Diamyd Administered Into Lymph Nodes in Individuals Recently Diagnosed With Type 1 Diabetes, Carryin…
Clinical Relevance of Typing HLA-DR7-DQ2
Study to Evaluate the Safety and Feasibility of Diamyd® in Individuals at Risk for Type 1 Diabetes
Oral Hypoglycemic Therapy for Monogenic Variant Carriers of the Joslin Medalist Study
Evaluation of a Booster Administration of GAD-alum (Diamyd®) in Individuals With Type 1 Diabetes
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ